TW200716544A - Organic compounds - Google Patents

Organic compounds

Info

Publication number
TW200716544A
TW200716544A TW095120194A TW95120194A TW200716544A TW 200716544 A TW200716544 A TW 200716544A TW 095120194 A TW095120194 A TW 095120194A TW 95120194 A TW95120194 A TW 95120194A TW 200716544 A TW200716544 A TW 200716544A
Authority
TW
Taiwan
Prior art keywords
manufacture
compound
organic compounds
novel
formula
Prior art date
Application number
TW095120194A
Other languages
English (en)
Inventor
Stuart John Mickel
Gottfried Sedelmeier
Hans Hirt
Frank Schafer
Michael Foulkes
Walter Prikosiovich
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200716544A publication Critical patent/TW200716544A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
TW095120194A 2005-06-08 2006-06-07 Organic compounds TW200716544A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0511686.8A GB0511686D0 (en) 2005-06-08 2005-06-08 Organic compounds

Publications (1)

Publication Number Publication Date
TW200716544A true TW200716544A (en) 2007-05-01

Family

ID=34835327

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095120194A TW200716544A (en) 2005-06-08 2006-06-07 Organic compounds

Country Status (24)

Country Link
US (2) US7767831B2 (zh)
EP (2) EP2080754A3 (zh)
JP (2) JP2008542415A (zh)
KR (1) KR20080014011A (zh)
CN (1) CN101193860B (zh)
AR (1) AR054374A1 (zh)
AU (1) AU2006256938B2 (zh)
BR (1) BRPI0611919A2 (zh)
CA (1) CA2608575A1 (zh)
EC (1) ECSP077986A (zh)
GB (1) GB0511686D0 (zh)
GT (1) GT200600208A (zh)
IL (1) IL187004A0 (zh)
MA (1) MA29563B1 (zh)
MX (1) MX2007015418A (zh)
NO (1) NO20080080L (zh)
NZ (2) NZ562889A (zh)
PE (2) PE20070075A1 (zh)
RU (1) RU2418785C2 (zh)
SG (1) SG155209A1 (zh)
TN (1) TNSN07465A1 (zh)
TW (1) TW200716544A (zh)
WO (1) WO2006131304A2 (zh)
ZA (1) ZA200709076B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0521083D0 (en) 2005-10-17 2005-11-23 Novartis Ag Organic compounds
DE102007049039A1 (de) 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
ES2442266T3 (es) 2007-12-24 2014-02-10 Dsm Ip Assets B.V. Síntesis convergente de inhibidores de renina y compuestos intermedios útiles en la misma
SI2189442T1 (sl) 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
RU2550691C2 (ru) * 2009-08-11 2015-05-10 Новартис Аг Раскрытие циклов лактонов и лактамов
WO2011051853A1 (en) 2009-10-29 2011-05-05 CarboDesign LLC Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren
WO2011098258A1 (en) * 2010-02-10 2011-08-18 Ratiopharm Gmbh Salts of aliskiren
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren
CN111423325A (zh) * 2020-04-26 2020-07-17 江苏凯迪恩医药科技有限公司 基于蒽醌类药物的双醋瑞因合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570108A (en) * 1982-07-06 1986-02-11 Stroede Aake Protection device for electrical incandescent lamps
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
CA2121898A1 (en) * 1994-04-21 1995-10-22 Stephen Hanessian Synthesis of prototypes for renin inhibitors
JP2005231999A (ja) * 2000-03-08 2005-09-02 Banyu Pharmaceut Co Ltd カルバペネム誘導体の製造方法
JP4900755B2 (ja) 2000-07-05 2012-03-21 ノバルティス ファーマ アーゲー 置換オクタノイルアミドの調製方法
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
ATE342887T1 (de) * 2000-12-14 2006-11-15 Speedel Pharma Ag Verfahren zur herstellung von aryloctanoyl-amiden
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
KR20080014011A (ko) 2008-02-13
PE20091359A1 (es) 2009-10-13
NO20080080L (no) 2008-01-04
CA2608575A1 (en) 2006-12-14
GT200600208A (es) 2007-03-28
NZ562889A (en) 2011-11-25
EP2080754A3 (en) 2010-06-02
EP2080754A2 (en) 2009-07-22
RU2007148226A (ru) 2009-07-20
CN101193860A (zh) 2008-06-04
BRPI0611919A2 (pt) 2010-10-05
GB0511686D0 (en) 2005-07-13
PE20070075A1 (es) 2007-03-16
AR054374A1 (es) 2007-06-20
MX2007015418A (es) 2008-02-21
WO2006131304A3 (en) 2007-07-19
CN101193860B (zh) 2013-01-02
MA29563B1 (fr) 2008-06-02
ZA200709076B (en) 2008-10-29
ECSP077986A (es) 2008-01-23
EP1896411A2 (en) 2008-03-12
JP2008542415A (ja) 2008-11-27
TNSN07465A1 (en) 2009-03-17
US20080207921A1 (en) 2008-08-28
IL187004A0 (en) 2008-02-09
AU2006256938B2 (en) 2009-12-17
US20100274027A1 (en) 2010-10-28
WO2006131304A2 (en) 2006-12-14
RU2418785C2 (ru) 2011-05-20
JP2013028607A (ja) 2013-02-07
NZ591010A (en) 2012-06-29
SG155209A1 (en) 2009-09-30
AU2006256938A1 (en) 2006-12-14
US7767831B2 (en) 2010-08-03

Similar Documents

Publication Publication Date Title
TNSN07465A1 (en) Organic compounds
JO2926B1 (en) Organic compounds
TN2009000401A1 (en) New methods
NZ598172A (en) Synthesis of boronic ester and acid compounds
WO2007091009A3 (en) Preparation of delmopinol
TW200726754A (en) Chemical process
MX2012004382A (es) Procedimiento para la preparación de compuestos útiles como inhibidores del transportador de glucosa dependiente de sodio 2.
ATE477234T1 (de) Synthese von phenolischen estern von hydroxymethylphenolen
WO2008155338A3 (en) Process for the synthesis of intermediates of renin inhibitors such as aliskiren
TNSN08142A1 (en) Synthesis of renin inhibitors involving a cycloaddition reaction
TW200612959A (en) Method for preparing hydroxamic acids
MX2009013869A (es) Proceso para hacer 2-amino-tiazolonas sustituidas.
BRPI0507318A (pt) métodos para reduzir um composto, para a produção de calcipotriol ou monoidrato de calcipotriol, e de um composto, e de reação da mistura de compostos, composto, e, uso de um composto
MY143324A (en) Process for preparing phosphorus compounds having phosphate-phosphonate bond
MX2010013758A (es) Procedimiento para elaborar 2-amino-tiazolonas sustituidas.
IL200323A0 (en) Synthesis of glyt-1 inhibitors
MXPA05012113A (es) Procedimiento para sintetizar intermediarios inhibidores de beta-lactamasa.
TW200730524A (en) Process for making heteroaryl amine intermediate compounds
WO2004091549A3 (en) Process for making alpha-substituted hydroxamic acids
TW200631926A (en) Process for the production of nitrobenzoles
TW200640835A (en) Process for the production of anilines
TH88107B (th) สารประกอบอินทรีย์
TH78688A (th) กรรมวิธีสำหรับการเตรียมไพราโซล
TH89325B (th) สารประกอบอินทรีย์
TH88107A (th) สารประกอบอินทรีย์